Click here to view the Humana Medical Policy Updates Updates » September 2024 Humana Medical…
BCBS Alabama Medical Policy Updates – September 2018
Click here to view the Blue Cross Blue Shield Alabama Medical Policy Updates »
September 2018 BCBS Alabama Medical Policy Updates:
- Adoptive Immunotherapy
- Allogeneic Pancreas Transplant
- Androgens and Anabolic Steroids
- Artificial Pancreas Device Systems
- Biologic Immunomodulators
- Bi-Ventricular Pacemakers (Cardiac Resynchronization Therapy) for the Treatment of Heart Failure
- Blepharoplasty, Brow Lift and Ptosis Repair
- Boniva (Ibandronate Sodium) Infusion
- BRAF Gene Mutation Variant Testing To Select Melanoma or Glioma Patients for Targeted Therapy
- Bronchial Thermoplasty
- Buprenorphine and Buprenorphine/Naloxone for Opioid Dependence
- Cardioverter Defibrillator: Implantable
- Chromosomal Microarray Testing for the Evaluation of Pregnancy Loss
- Combined Liver-Kidney Transplant
- Composite Tissue Allotransplantation (CTA) of the Hand and Face
- Cranial Electrotherapy Stimulation (CES) and Auricular Electrostimulation
- Cryosurgical Ablation of Miscellaneous Solid Tumors Other than Liver, Prostate, or Dermatologic Tumors
- Extracorporeal Shock Wave Treatment for Plantar Fasciitis and Other Musculoskeletal Conditions
- Gene Expression Profiling for Cutaneous Melanoma
- Genetic Testing for Diagnosis and Management of Mental Health Conditions
- Genetic Testing for Genotype-Guided Tamoxifen Treatment
- Genetic Testing for Li-Fraumeni Syndrome
- Genetic Testing for Mitochondrial Disorders
- Gocovri (amantadine)
- Heart/Lung Transplant
- Helicobacter Pylori Testing
- Hereditary Angioedema
- In Vitro Chemoresistance and Chemosensitivity Assays
- Injectable Bulking Agents for the Treatment of Urinary and Fecal Incontinence
- Islet Transplantation
- Isolated Small Bowel Transplant
- JAK2,MPL, and CALRTesting for Myeloproliferative Neoplasms
- Kidney Transplant
- Knee Arthroplasty
- KRAS, NRAS and BRAF Variant Analysis in Metastatic Colorectal Cancer
- Laparoscopic and Percutaneous Techniques for the Myolysis of Uterine Fibroids
- Liver Transplant
- Locoregional Therapies for Hepatocellular Carcinoma and Metastatic Liver Carcinoma and Metastatic Carcinoid Tumors of the Liver
- Lumbar Spinal Fusion Surgery
- Magnetic Resonance Guided Focused Ultrasound (MRgFUS)
- Magnetic Resonance Imaging (MRI) Targeted Biopsy of the Prostate
- Management of Excessive Skin and Subcutaneous Tissue
- Measurement of Exhaled Nitric Oxide and Exhaled Breath Condensate in the Diagnosis and Management of Respiratory Disorders
- Measurement of Serum Antibodies to Infliximab, Adalimumab, and Vedolizumab
- Medical Management of Obstructive Sleep Apnea Syndrome
- Molecular Markers in Fine Needle Aspirates of the Thyroid
- Mozobil (Plerixafor)
- Multigene Expression Assay for Predicting Recurrence in Colon Cancer
- Nulojix® (belatacept)
- Nutritional Treatment of Childhood Medical Conditions
- Occlusion of Uterine Arteries Using Transcatheter Embolization or Laparoscopic Occlusion to Treat Uterine Fibroids
- Oncologic Applications of Photodynamic Therapy, Including Barrett Esophagus
- Opioid Immediate Release
- Oscillatory Devices for the Treatment of Cystic Fibrosis and Other Respiratory Conditions
- Ovarian and Internal Iliac Vein Embolization as Treatment of Pelvic Congestion Syndrome
- Oxygen Therapy
- Patient-Specific Instrumentation for Joint Arthroplasty
- Pelvic Floor Stimulation as a Treatment of Urinary and Fecal Incontinence
- Percutaneous Electrical Nerve Stimulation (PENS) and Percutaneous Neuromodulation Therapy (PNT)
- Percutaneous Tibial Nerve Stimulation
- Periureteral Bulking Agents as a Treatment of Vesicoureteral Reflux
- Polysomnography for Respiratory Sleep Disorders Testing
- Preimplantation Genetic Testing
- Prophylactic Risk-Reducing Mastectomy
- Proteogenomic Testing for Patients with Cancer (GPS Cancer Test)
- Qutenza® (capsaicin) 8% Patch
- Saturation Biopsy for Diagnosis, Staging, and Management of Prostate Cancer
- Small Bowel/Liver and Multivisceral Transplant
- Surgical Treatments for Lymphedema
- Three-Dimensional Printed Orthopedic Implants
- Tumor-Treatment Fields Therapy for Glioblastoma
- Urinary Biomarkers for Cancer Screening, Diagnosis, and Surveillance
- Whole Gland Cryoablation of Prostate Cancer
Added 9/27/2018;
- Computed Tomography to Detect Coronary Artery Calcification
- Constraint Induced Movement or Language Therapy
- Cytochrome P450 Genotyping Genotype-Guided Treatment Strategy
- Genetic Testing for Diagnosis and Management of Mental Health Conditions
- Genetic Testing for Genotype-Guided Tamoxifen Treatment
- Genetic Testing for Inherited Cancer Predisposition and/or Pharmacogenetics related to Cancer Treatment
- Heart Transplant
- High Resolution Anoscopy
- Identification of Microorganisms Using Nucleic Acid Probes
- JAK2,MPL, and CALR Testing for Myeloproliferative Neoplasms
- KRAS, NRAS and BRAF Variant Analysis in Metastatic Colorectal Cancer
- Levonorgestrel-releasing Intrauterine System (LNG-IUS) (Mirena ) for Heavy Menstrual Bleeding
- Lung and Lobar Lung Transplant
- Magnetic Resonance Neurography
- Magnetic Resonance Spectroscopy
- Microwave Tumor Ablation
- Myocardial Sympathetic Innervation Imaging in Patients with Heart Failure
- Peripheral Nerve Stimulation of the Trunk or Limbs for Treatment of Pain
- Pharmacogenetic Testing for Pain Management
- Positron Emission Mammography (PEM)
- Radiofrequency Ablation of the Renal Sympathetic Nerves as a Treatment for Resistant Hypertension
- Radioimmunoscintigraphy (Monoclonal Antibody Imaging) with Indium-111 Capromab Pendetide for Prostate Cancer
- Serologic Diagnosis of Celiac Disease
- Serum Biomarker Panel Testing for Systemic Lupus Erythematosus and Other Connective Tissue Diseases
- Serum Tumor Markers for Breast and Gastrointestinal Malignancies
- Transvaginal and Transurethral Radiofrequency Tissue Remodeling for Urinary Stress Incontinence
Click here to view the Blue Cross Blue Shield Alabama Medical Policy Updates »
Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.
Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!
Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.
Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.
Related Posts
